Pee Cee Cosma Sope Board of Directors

Get the latest insights into the leadership at Pee Cee Cosma Sope. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Mayank Jain Executive Chairman
Mr. Ankur Jain Managing Director
Mr. Ankit Jain Whole Time Director
Mrs. Babita Agarwal Independent Director
Mr. Anil Gupta Independent Director
Mr. Kshitiz Agarwal Additional Director

Pee Cee Cosma Sope Share price

PCCOSMA

459.9

15.10 (3.39%)
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

463.00

Today's Low

451.05

52 Week Low

435.05

52 Week High

978.60

The current prices are delayed, login to your account for live prices

Pee Cee Cosma Sope FAQs

The board at Pee Cee Cosma Sope consists of experienced professionals, including Mr. Mayank Jain , Mr. Ankur Jain , and others, overseeing the company’s strategic and corporate governance.

Directors at Pee Cee Cosma Sope are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Mayank Jain is the current chairman at Pee Cee Cosma Sope.

Executive directors at Pee Cee Cosma Sope are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Pee Cee Cosma Sope adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Pee Cee Cosma Sope, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.